Caribou Biosciences, Inc. Common Stock

CRBUNASDAQ • USD
0.35 USD
↘ 0.01 (2.74%)🟢PRE MARKET (AS OF 04:22 AM EST)
🟢Market: OPEN

Caribou Biosciences, Inc. Common Stock (CRBU) trades at $0.35 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CRBU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.37
High?$0.37
Low?$0.35
Prev. Close?$0.36
Volume?392
Avg. Volume?4.6M
VWAP?$0.36
Rel. Volume?0.00x
Bid / Ask
Bid?$0.31 × 100
Ask?$0.42 × 100
Spread?$0.11
Midpoint?$0.37
Valuation & Ratios
Market Cap?38.9M
Shares Out?108.0M
Float?93.2M
Float %?86.9%
P/E Ratio?N/A
P/B Ratio?0.51
EPS?-$0.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Employees
97
Market Cap
39.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-07-23
Address
2929 7TH STREET, SUITE 105
BERKELEY, CA 94710
Phone: 510-982-6030
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?-9.18Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.98%High
Short Interest?14.9M
Days to Cover?6.0
Free Float93.2M
Avg Daily Volume2.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.97Strong
Quick Ratio?4.97Strong
Cash Ratio?1.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.51CHEAP▾
P/S?
Peers
100
S&P
37
4.12FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
Peers
100
S&P
86
1.36CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-133.9%WEAK▾
ROA?
S&P
3
-83.4%WEAK▾
Cash Flow & Enterprise
FCF?$-93237000
Enterprise Value?$12.8M
Fundamentals ratios updated end of day